Where PTC Therapeutics Stands With Analysts
Portfolio Pulse from Benzinga Insights
Analysts have provided various ratings for PTC Therapeutics (NASDAQ:PTCT) within the last quarter, with an average price target of $54.42 versus the current price of $38.02. This average price target has increased by 2.24% over the past month.
August 07, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a bullish outlook on PTC Therapeutics with an average price target of $54.42, indicating potential upside from the current price of $38.02.
The average price target given by analysts indicates a potential upside for PTC Therapeutics. This suggests that they believe the stock will perform well in the short term. The increase in the average price target over the past month also shows growing confidence in the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100